Skip to main content

Table 1 Distribution by country of nepafenac trial participants

From: Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations

Country

Number of subjects

% of total subjects

United States

500

83.6

Panama

26

4.3

Puerto Rico

54

9

Other

18

3

Total

598

100

Back to article page

Trials

ISSN: 1745-6215